Glioblastoma

USC-licensed startup NeOnc Technologies gets NASDAQ listing

Read more

Sun Pharma and Philogen sign global licensing agreement for Fibromun

Read more

Zydus gets COFEPRIS nod to market  Bhava to treat various cancers

Read more

Trodelvy from Immunomedics gets US FDA orphan drug designation for glioblastoma

Read more

Glioblastoma treatment market will expand five-fold to $3.3 billion by 2024: GlobalData

Read more